Public Charity

FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY

Based in OMAHA, NE, FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY operates as a Public Charity. The organization reported $6.9M in revenue, $6.8M in expenses, $3.8M in total assets for fiscal year 2025.

EIN: 841363353 OMAHA, NE Cancer Research NTEE: H30 Latest filing: 2025
Total Revenue$6.9M
Total Expenses$6.8M
Total Assets$3.8M
Grant Records0
Filing Years2020–2025

Mission

FACT IS A NON-PROFIT CORPORATION FOUNDED TO IMPROVE THE QUALITY OF CELLULAR THERAPY THROUGH PEER-DEVELOPED STANDARDS, EDUCATION AND ACCREDITATION FOR THE BENEFIT OF PATIENTS.

Where $100 goes at Foundation for the Accreditation of Cellular Therapy

How Foundation for the Accreditation of Cellular Therapy divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.

$68 Programs the work itself
$32 Management running the organization
$0 Fundraising none reported

No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.

Inside the $68 for programs

$54
Accreditation
80% of program spending
$7
Training & education
10% of program spending
$4
Fact consulting services
5% of program spending

Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.

Share on LinkedIn Share on Facebook
Add this to your website

Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Officers & Directors

BOARD MEMBER Alan Balch Phd
TREASURER Carlos Ramos Md
PRESIDENT Catherine Bollard Md
PAST PRESIDENT C Fred Lemaistre Md
CHIEF EXEC OFFICER David Schmahl
BOARD MEMBER Eneida Nemecek Md

Officer compensation and complete director data available with membership.

Financial Trends

Year Revenue Expenses Assets
2025 $6.9M $6.8M $3.8M
2024 $7.2M $6.3M $3.8M
2023 $5.5M $5.0M $2.9M
2022 $4.7M $4.4M $2.4M
2020 $3.3M $2.7M $1.7M

Between 2020 and 2025, reported annual revenue grew from $3.3M to $6.9M (+105%), with total assets most recently reported at $3.8M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY

Complete financials, all 0 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time